These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15916439

  • 1. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK, Misselwitz B, Tso LS, Doble DM, Schmitt-Willich H, Raymond KN.
    J Med Chem; 2005 Jun 02; 48(11):3874-7. PubMed ID: 15916439
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J, Churchill DG, Botta M, Raymond KN.
    Inorg Chem; 2004 Sep 06; 43(18):5492-4. PubMed ID: 15332797
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
    Yan GP, Hu B, Liu ML, Li LY.
    J Pharm Pharmacol; 2005 Mar 06; 57(3):351-7. PubMed ID: 15807991
    [Abstract] [Full Text] [Related]

  • 4. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S, Torres S, Martins AF, Martins JA, André JP, Helm L, Prata MI, Santos AC, Geraldes CF.
    Dalton Trans; 2009 Jun 28; (24):4656-70. PubMed ID: 19513474
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS, Garmestani K, Bryant LH, Milenic DE, Overstreet T, Birch N, Le T, Brady ED, Brechbiel MW.
    J Med Chem; 2006 Mar 23; 49(6):2055-62. PubMed ID: 16539394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C, Anelli PL, Lorusso V, Morisetti A, Maggioni F, Zheng J, Uggeri F, Cavagna FM.
    Invest Radiol; 2006 Mar 23; 41(3):279-91. PubMed ID: 16481911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 23; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 12. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M, Idée JM, Medina C, Robic C, Sabatou M, Corot C.
    Biometals; 2008 Aug 23; 21(4):469-90. PubMed ID: 18344005
    [Abstract] [Full Text] [Related]

  • 13. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL, Hollister R, Peng X, Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Eck J, Desai VC, Raymond G, Kinter LB, Desser TS, Rubin DL.
    Bioconjug Chem; 1999 Aug 23; 10(3):361-70. PubMed ID: 10346865
    [Abstract] [Full Text] [Related]

  • 14. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z, Li W, Li X, Pei F, Li Y, Lei H.
    Magn Reson Imaging; 2007 Apr 23; 25(3):412-7. PubMed ID: 17371733
    [Abstract] [Full Text] [Related]

  • 15. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
    Pierre VC, Melchior M, Doble DM, Raymond KN.
    Inorg Chem; 2004 Dec 27; 43(26):8520-5. PubMed ID: 15606201
    [Abstract] [Full Text] [Related]

  • 16. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
    Assfalg M, Gianolio E, Zanzoni S, Tomaselli S, Russo VL, Cabella C, Ragona L, Aime S, Molinari H.
    J Med Chem; 2007 Nov 01; 50(22):5257-68. PubMed ID: 17915850
    [Abstract] [Full Text] [Related]

  • 17. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May 01; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 18. A highly stable gadolinium complex with a fast, associative mechanism of water exchange.
    Thompson MK, Botta M, Nicolle G, Helm L, Aime S, Merbach AE, Raymond KN.
    J Am Chem Soc; 2003 Nov 26; 125(47):14274-5. PubMed ID: 14624565
    [Abstract] [Full Text] [Related]

  • 19. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K, Kikuchi K, Terai T, Komatsu T, Nagano T.
    Chemistry; 2008 Nov 26; 14(3):987-95. PubMed ID: 17992679
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan 26; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.